Dr. Alexander Klibanov received his M.S. in Chemistry and Ph.D. in Chemical Enzymology both from Moscow University in Russia. Following his immigration to the United States in 1977, he spent 1.5 years as a postdoctoral associate in the Department of Chemistry at the University of California, San Diego, before joining the faculty at the Massachusetts Institute of Technology (MIT) where he is currently an Endowed-Chaired Professor of Chemistry and Bioengineering. His current research interests include medicinal chemistry, new antimicrobial materials; enzyme chemistry and biotechnology; and pharmaceutical formulations. He has authored over 310 scientific papers and 21 issued U.S. patents (plus many pending), has given over 370 invited lectures, including many named ones, all over the world, and is a member of 12 journal editorial boards. Dr. Klibanov has received numerous prestigious professional awards, including the Leo Friend Award, the Ipatieff Prize, the Marvin J. Johnson Award, and the Arthur C. Cope Scholar Award, all from the American Chemical Society, as well as the International Enzyme Engineering Prize. He was elected both to the National Academy of Sciences and to the National Academy of Engineering of the United States. Dr. Klibanov has started six pharmaceutical companies and has been a scientific advisor, consultant, and/or director for numerous pharmaceutical, medical device, and biotechnology companies, as well as law firms in patent and other IP litigations.

Dr. Alexander Klibanov's research interests include:  Enzyme chemistry and biotechnology  Antimicrobial polymers  Stabilization and formulation of macromolecular pharmaceuticals  Medicinal and formulation chemistry  Protein drug delivery  Enzymes as stereoselective catalysts in organic synthesis